Industry: Service & Software
Published Date: 2024-01-08
Pages: 109 Pages
Report ld: 3007655
Request Sample
Customized Report
Preclinical Contract Research Organization (CRO) Market Size(US$)

CAGR 2024-2030
8.7%
Market Size,2030
USD 26,050
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
A preclinical CRO (contract research organizations) helps new medical product developers (including devices, drugs, biologics and more) prove those products are safe and effective in live models the FDA deems approximate as closely as possible the human anatomy prior to those devices enter clinical trials (or receiving other approvals like 510Ks) or use for human care.
The global market for Preclinical Contract Research Organization (CRO) was estimated to be worth US$ 14510 million in 2023 and is forecast to a readjusted size of US$ 26050 million by 2030 with a CAGR of 8.7% during the forecast period 2024-2030
Increased R&D budget for drug development is leading to rising demand for preclinical Contract Research Organization (CRO) services, and increasing early research activities in drug discovery process coupled with rising outsourcing for preclinical CRO services, thus boosting the market growth during the forecast period.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Preclinical Contract Research Organization (CRO), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Preclinical Contract Research Organization (CRO) by region & country, by Type, and by Application.
The Preclinical Contract Research Organization (CRO) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preclinical Contract Research Organization (CRO).
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Preclinical Contract Research Organization (CRO) manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Preclinical Contract Research Organization (CRO) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Preclinical Contract Research Organization (CRO) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Preclinical Contract Research Organization (CRO) Product Introduction
1.2 Global Preclinical Contract Research Organization (CRO) Market Size Forecast
1.3 Preclinical Contract Research Organization (CRO) Market Trends & Drivers
1.3.1 Preclinical Contract Research Organization (CRO) Industry Trends
1.3.2 Preclinical Contract Research Organization (CRO) Market Drivers & Opportunity
1.3.3 Preclinical Contract Research Organization (CRO) Market Challenges
1.3.4 Preclinical Contract Research Organization (CRO) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Preclinical Contract Research Organization (CRO) Players Revenue Ranking (2023)
2.2 Global Preclinical Contract Research Organization (CRO) Revenue by Company (2019-2024)
2.3 Key Companies Preclinical Contract Research Organization (CRO) Manufacturing Base Distribution and Headquarters
2.4 Key Companies Preclinical Contract Research Organization (CRO) Product Offered
2.5 Key Companies Time to Begin Mass Production of Preclinical Contract Research Organization (CRO)
2.6 Preclinical Contract Research Organization (CRO) Market Competitive Analysis
2.6.1 Preclinical Contract Research Organization (CRO) Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Preclinical Contract Research Organization (CRO) Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical Contract Research Organization (CRO) as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Bioanalysis and DMPK Studies
3.1.2 Toxicology Testing
3.1.3 Safety Pharmacology
3.1.4 Others
3.2 Global Preclinical Contract Research Organization (CRO) Sales Value by Type
3.2.1 Global Preclinical Contract Research Organization (CRO) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Preclinical Contract Research Organization (CRO) Sales Value, by Type (2019-2030)
3.2.3 Global Preclinical Contract Research Organization (CRO) Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical Companies
4.1.2 Medical Device Companies
4.1.3 Others
4.2 Global Preclinical Contract Research Organization (CRO) Sales Value by Application
4.2.1 Global Preclinical Contract Research Organization (CRO) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Preclinical Contract Research Organization (CRO) Sales Value, by Application (2019-2030)
4.2.3 Global Preclinical Contract Research Organization (CRO) Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Preclinical Contract Research Organization (CRO) Sales Value by Region
5.1.1 Global Preclinical Contract Research Organization (CRO) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Preclinical Contract Research Organization (CRO) Sales Value by Region (2019-2024)
5.1.3 Global Preclinical Contract Research Organization (CRO) Sales Value by Region (2025-2030)
5.1.4 Global Preclinical Contract Research Organization (CRO) Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Preclinical Contract Research Organization (CRO) Sales Value, 2019-2030
5.2.2 North America Preclinical Contract Research Organization (CRO) Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Preclinical Contract Research Organization (CRO) Sales Value, 2019-2030
5.3.2 Europe Preclinical Contract Research Organization (CRO) Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Preclinical Contract Research Organization (CRO) Sales Value, 2019-2030
5.4.2 Asia Pacific Preclinical Contract Research Organization (CRO) Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Preclinical Contract Research Organization (CRO) Sales Value, 2019-2030
5.5.2 South America Preclinical Contract Research Organization (CRO) Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Preclinical Contract Research Organization (CRO) Sales Value, 2019-2030
5.6.2 Middle East & Africa Preclinical Contract Research Organization (CRO) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Preclinical Contract Research Organization (CRO) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Preclinical Contract Research Organization (CRO) Sales Value
6.3 United States
6.3.1 United States Preclinical Contract Research Organization (CRO) Sales Value, 2019-2030
6.3.2 United States Preclinical Contract Research Organization (CRO) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Preclinical Contract Research Organization (CRO) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Preclinical Contract Research Organization (CRO) Sales Value, 2019-2030
6.4.2 Europe Preclinical Contract Research Organization (CRO) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Preclinical Contract Research Organization (CRO) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Preclinical Contract Research Organization (CRO) Sales Value, 2019-2030
6.5.2 China Preclinical Contract Research Organization (CRO) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Preclinical Contract Research Organization (CRO) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Preclinical Contract Research Organization (CRO) Sales Value, 2019-2030
6.6.2 Japan Preclinical Contract Research Organization (CRO) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Preclinical Contract Research Organization (CRO) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Preclinical Contract Research Organization (CRO) Sales Value, 2019-2030
6.7.2 South Korea Preclinical Contract Research Organization (CRO) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Preclinical Contract Research Organization (CRO) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Preclinical Contract Research Organization (CRO) Sales Value, 2019-2030
6.8.2 Southeast Asia Preclinical Contract Research Organization (CRO) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Preclinical Contract Research Organization (CRO) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Preclinical Contract Research Organization (CRO) Sales Value, 2019-2030
6.9.2 India Preclinical Contract Research Organization (CRO) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Preclinical Contract Research Organization (CRO) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Charles River
7.1.1 Charles River Profile
7.1.2 Charles River Main Business
7.1.3 Charles River Preclinical Contract Research Organization (CRO) Products, Services and Solutions
7.1.4 Charles River Preclinical Contract Research Organization (CRO) Revenue (US$ Million) & (2019-2024)
7.1.5 Charles River Recent Developments
7.2 Wuxi AppTec
7.2.1 Wuxi AppTec Profile
7.2.2 Wuxi AppTec Main Business
7.2.3 Wuxi AppTec Preclinical Contract Research Organization (CRO) Products, Services and Solutions
7.2.4 Wuxi AppTec Preclinical Contract Research Organization (CRO) Revenue (US$ Million) & (2019-2024)
7.2.5 Wuxi AppTec Recent Developments
7.3 Labcorp
7.3.1 Labcorp Profile
7.3.2 Labcorp Main Business
7.3.3 Labcorp Preclinical Contract Research Organization (CRO) Products, Services and Solutions
7.3.4 Labcorp Preclinical Contract Research Organization (CRO) Revenue (US$ Million) & (2019-2024)
7.3.5 Eurofins Scientific Recent Developments
7.4 Eurofins Scientific
7.4.1 Eurofins Scientific Profile
7.4.2 Eurofins Scientific Main Business
7.4.3 Eurofins Scientific Preclinical Contract Research Organization (CRO) Products, Services and Solutions
7.4.4 Eurofins Scientific Preclinical Contract Research Organization (CRO) Revenue (US$ Million) & (2019-2024)
7.4.5 Eurofins Scientific Recent Developments
7.5 PPD, Inc.
7.5.1 PPD, Inc. Profile
7.5.2 PPD, Inc. Main Business
7.5.3 PPD, Inc. Preclinical Contract Research Organization (CRO) Products, Services and Solutions
7.5.4 PPD, Inc. Preclinical Contract Research Organization (CRO) Revenue (US$ Million) & (2019-2024)
7.5.5 PPD, Inc. Recent Developments
7.6 ICON Plc.
7.6.1 ICON Plc. Profile
7.6.2 ICON Plc. Main Business
7.6.3 ICON Plc. Preclinical Contract Research Organization (CRO) Products, Services and Solutions
7.6.4 ICON Plc. Preclinical Contract Research Organization (CRO) Revenue (US$ Million) & (2019-2024)
7.6.5 ICON Plc. Recent Developments
7.7 Pharmaron
7.7.1 Pharmaron Profile
7.7.2 Pharmaron Main Business
7.7.3 Pharmaron Preclinical Contract Research Organization (CRO) Products, Services and Solutions
7.7.4 Pharmaron Preclinical Contract Research Organization (CRO) Revenue (US$ Million) & (2019-2024)
7.7.5 Pharmaron Recent Developments
7.8 Inotiv
7.8.1 Inotiv Profile
7.8.2 Inotiv Main Business
7.8.3 Inotiv Preclinical Contract Research Organization (CRO) Products, Services and Solutions
7.8.4 Inotiv Preclinical Contract Research Organization (CRO) Revenue (US$ Million) & (2019-2024)
7.8.5 Inotiv Recent Developments
7.9 ChemPartner
7.9.1 ChemPartner Profile
7.9.2 ChemPartner Main Business
7.9.3 ChemPartner Preclinical Contract Research Organization (CRO) Products, Services and Solutions
7.9.4 ChemPartner Preclinical Contract Research Organization (CRO) Revenue (US$ Million) & (2019-2024)
7.9.5 ChemPartner Recent Developments
7.10 JOINN Lab
7.10.1 JOINN Lab Profile
7.10.2 JOINN Lab Main Business
7.10.3 JOINN Lab Preclinical Contract Research Organization (CRO) Products, Services and Solutions
7.10.4 JOINN Lab Preclinical Contract Research Organization (CRO) Revenue (US$ Million) & (2019-2024)
7.10.5 JOINN Lab Recent Developments
7.11 EVOTEC
7.11.1 EVOTEC Profile
7.11.2 EVOTEC Main Business
7.11.3 EVOTEC Preclinical Contract Research Organization (CRO) Products, Services and Solutions
7.11.4 EVOTEC Preclinical Contract Research Organization (CRO) Revenue (US$ Million) & (2019-2024)
7.11.5 EVOTEC Recent Developments
7.12 Medicilon
7.12.1 Medicilon Profile
7.12.2 Medicilon Main Business
7.12.3 Medicilon Preclinical Contract Research Organization (CRO) Products, Services and Solutions
7.12.4 Medicilon Preclinical Contract Research Organization (CRO) Revenue (US$ Million) & (2019-2024)
7.12.5 Medicilon Recent Developments
7.13 Crown Bioscience
7.13.1 Crown Bioscience Profile
7.13.2 Crown Bioscience Main Business
7.13.3 Crown Bioscience Preclinical Contract Research Organization (CRO) Products, Services and Solutions
7.13.4 Crown Bioscience Preclinical Contract Research Organization (CRO) Revenue (US$ Million) & (2019-2024)
7.13.5 Crown Bioscience Recent Developments
7.14 Champion Oncology
7.14.1 Champion Oncology Profile
7.14.2 Champion Oncology Main Business
7.14.3 Champion Oncology Preclinical Contract Research Organization (CRO) Products, Services and Solutions
7.14.4 Champion Oncology Preclinical Contract Research Organization (CRO) Revenue (US$ Million) & (2019-2024)
7.14.5 Champion Oncology Recent Developments
8 Industry Chain Analysis
8.1 Preclinical Contract Research Organization (CRO) Industrial Chain
8.2 Preclinical Contract Research Organization (CRO) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Preclinical Contract Research Organization (CRO) Sales Model
8.5.2 Sales Channel
8.5.3 Preclinical Contract Research Organization (CRO) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Preclinical Contract Research Organization (CRO) market size was US$ 19380 million in 2025 and is forecast to reach a readjusted size of US$ 33320 million by 2032 with a CAGR of 8.2% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 92
USD 4250.00
(Single User License)
The global market for Preclinical Contract Research Organization (CRO) was estimated to be worth US$ 19380 million in 2025 and is projected to reach US$ 33320 million, growing at a CAGR of 8.2% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 107
USD 3950.00
(Single User License)
The global Preclinical Contract Research Organization (CRO) market was valued at US$ 19380 million in 2025 and is anticipated to reach US$ 33320 million by 2032, at a CAGR of 8.2% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 118
USD 2900.00
(Single User License)
The global Preclinical Contract Research Organization (CRO) market is projected to grow from US$ 17780 million in 2024 to US$ 31040 million by 2031, at a CAGR of 8.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-16
Pages: 138
USD 4900.00
(Single User License)
The global Preclinical Contract Research Organization (CRO) market size was US$ 17780 million in 2024 and is forecast to a readjusted size of US$ 31040 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.
Published Date: 2025-11-16
Pages: 92
USD 4250.00
(Single User License)
The global market for Preclinical Contract Research Organization (CRO) was estimated to be worth US$ 17780 million in 2024 and is forecast to a readjusted size of US$ 31040 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.
Published Date: 2025-06-01
Pages: 107
USD 3950.00
(Single User License)
The global Preclinical Contract Research Organization (CRO) market is projected to grow from US$ 19380 million in 2025 to US$ 31040 million by 2031, at a Compound Annual Growth Rate (CAGR) of 8.2% during the forecast period.
Published Date: 2025-06-01
Pages: 138
USD 4900.00
(Single User License)
The global market for Preclinical Contract Research Organization (CRO) was valued at US$ 17780 million in the year 2024 and is projected to reach a revised size of US$ 31040 million by 2031, growing at a CAGR of 8.2% during the forecast period.
Published Date: 2025-06-01
Pages: 90
USD 2900.00
(Single User License)
A preclinical CRO (contract research organizations) helps new medical product developers (including devices, drugs, biologics and more) prove those products are safe and effective in live models the FDA deems approximate as closely as possible the human anatomy prior to those devices enter clinical trials (or receiving other approvals like 510Ks) or use for human care.
Published Date: 2024-04-12
Pages: 106
USD 4900.00
(Single User License)
A preclinical CRO (contract research organizations) helps new medical product developers (including devices, drugs, biologics and more) prove those products are safe and effective in live models the FDA deems approximate as closely as possible the human anatomy prior to those devices enter clinical trials (or receiving other approvals like 510Ks) or use for human care.
Published Date: 2024-01-12
Pages: 82
USD 2900.00
(Single User License)
The global Preclinical Contract Research Organization (CRO) market size was US$ 19380 million in 2025 and is forecast to reach a readjusted size of US$ 33320 million by 2032 with a CAGR of 8.2% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 92
The global market for Preclinical Contract Research Organization (CRO) was estimated to be worth US$ 19380 million in 2025 and is projected to reach US$ 33320 million, growing at a CAGR of 8.2% from 2026 to 2032.
Published: 2026-03-06
Pages: 107
The global Preclinical Contract Research Organization (CRO) market was valued at US$ 19380 million in 2025 and is anticipated to reach US$ 33320 million by 2032, at a CAGR of 8.2% from 2026 to 2032.
Published: 2026-03-06
Pages: 118
The global Preclinical Contract Research Organization (CRO) market is projected to grow from US$ 17780 million in 2024 to US$ 31040 million by 2031, at a CAGR of 8.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-16
Pages: 138
The global Preclinical Contract Research Organization (CRO) market size was US$ 17780 million in 2024 and is forecast to a readjusted size of US$ 31040 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.
Published: 2025-11-16
Pages: 92
The global market for Preclinical Contract Research Organization (CRO) was estimated to be worth US$ 17780 million in 2024 and is forecast to a readjusted size of US$ 31040 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.
Published: 2025-06-01
Pages: 107
The global Preclinical Contract Research Organization (CRO) market is projected to grow from US$ 19380 million in 2025 to US$ 31040 million by 2031, at a Compound Annual Growth Rate (CAGR) of 8.2% during the forecast period.
Published: 2025-06-01
Pages: 138
The global market for Preclinical Contract Research Organization (CRO) was valued at US$ 17780 million in the year 2024 and is projected to reach a revised size of US$ 31040 million by 2031, growing at a CAGR of 8.2% during the forecast period.
Published: 2025-06-01
Pages: 90
A preclinical CRO (contract research organizations) helps new medical product developers (including devices, drugs, biologics and more) prove those products are safe and effective in live models the FDA deems approximate as closely as possible the human anatomy prior to those devices enter clinical trials (or receiving other approvals like 510Ks) or use for human care.
Published: 2024-04-12
Pages: 106
A preclinical CRO (contract research organizations) helps new medical product developers (including devices, drugs, biologics and more) prove those products are safe and effective in live models the FDA deems approximate as closely as possible the human anatomy prior to those devices enter clinical trials (or receiving other approvals like 510Ks) or use for human care.
Published: 2024-01-12
Pages: 82
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now